HHS and the U.S. Division of Protection on Wednesday signed an settlement underneath which the companies will proceed collaborating over the subsequent two years to handle the pandemic and future public well being emergencies.
As a part of their alliance, the DOD stated it not too long ago awarded $650 million to a number of firms to increase COVID-19 testing for elementary faculties, underserved populations, and congregate settings equivalent to homeless shelters.
The settlement means the 2 companies will work to increase home industrial capability of well being and medical assets, procure diagnostics and medical provides for the Strategic Nationwide Stockpile, and speed up the event, manufacture, and distribution of COVID-19 vaccines and therapeutics.
Particularly, the Workplace of the Underneath Secretary of Protection for Acquisition and Sustainment, by means of the Protection Assisted Acquisition Cell, will assessment assisted acquisition requests from HHS, decide which acquisition authorities and assets are finest suited to assist the efforts, and execute agreements with business to satisfy the outlined necessities, the DOD stated.
The settlement will stay in impact till not less than Sept. 30, 2023.
The DOD stated it has dealt with over $26 billion in funding on behalf of the HHS together with a $231.8 million contract for an at-home COVID take a look at.
This story first appeared in our sister publication, 360Dx, which supplies in-depth protection of in vitro diagnostics and the scientific lab market.